These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 30447707)

  • 1. The Properties of Cytokines in Multiple Sclerosis: Pros and Cons.
    Wang K; Song F; Fernandez-Escobar A; Luo G; Wang JH; Sun Y
    Am J Med Sci; 2018 Dec; 356(6):552-560. PubMed ID: 30447707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronal injury in chronic CNS inflammation.
    Zindler E; Zipp F
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage.
    Brück W
    J Neurol; 2005 Nov; 252 Suppl 5():v3-9. PubMed ID: 16254699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging role of IL-16 in cytokine-mediated regulation of multiple sclerosis.
    Skundric DS; Cruikshank WW; Montgomery PC; Lisak RP; Tse HY
    Cytokine; 2015 Oct; 75(2):234-48. PubMed ID: 25703787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandins in pathogenesis and treatment of multiple sclerosis.
    Mirshafiey A; Jadidi-Niaragh F
    Immunopharmacol Immunotoxicol; 2010 Dec; 32(4):543-54. PubMed ID: 20233088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Th17 cell, the new player of neuroinflammatory process in multiple sclerosis.
    Jadidi-Niaragh F; Mirshafiey A
    Scand J Immunol; 2011 Jul; 74(1):1-13. PubMed ID: 21338381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune cell trafficking across the barriers of the central nervous system in multiple sclerosis and stroke.
    Lopes Pinheiro MA; Kooij G; Mizee MR; Kamermans A; Enzmann G; Lyck R; Schwaninger M; Engelhardt B; de Vries HE
    Biochim Biophys Acta; 2016 Mar; 1862(3):461-71. PubMed ID: 26527183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-17A and Multiple Sclerosis: Signaling Pathways, Producing Cells and Target Cells in the Central Nervous System.
    Kolbinger F; Huppertz C; Mir A; Padova FD
    Curr Drug Targets; 2016; 17(16):1882-1893. PubMed ID: 26953244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine networks in multiple sclerosis: lost in translation.
    Codarri L; Fontana A; Becher B
    Curr Opin Neurol; 2010 Jun; 23(3):205-11. PubMed ID: 20442570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological Approaches Towards Cancer and Inflammation: A Cross Talk.
    Qu X; Tang Y; Hua S
    Front Immunol; 2018; 9():563. PubMed ID: 29662489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Janus faces of microglia in multiple sclerosis.
    Sanders P; De Keyser J
    Brain Res Rev; 2007 Jun; 54(2):274-85. PubMed ID: 17383006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunopathology of multiple sclerosis.
    Fox EJ
    Neurology; 2004 Dec; 63(12 Suppl 6):S3-7. PubMed ID: 15623668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytokines in MS lesion].
    Kato H; Suzumura A
    Nihon Rinsho; 2003 Aug; 61(8):1428-34. PubMed ID: 12962034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proinflammatory cytokines regulate antigen-independent T-cell activation by two separate calcium-signaling pathways in multiple sclerosis patients.
    Martino G; Grohovaz F; Brambilla E; Codazzi F; Consiglio A; Clementi E; Filippi M; Comi G; Grimaldi LM
    Ann Neurol; 1998 Mar; 43(3):340-9. PubMed ID: 9506551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recent prognosis on etiology and pathophysiology of multiple sclerosis].
    Niino M
    Nihon Rinsho; 2013 May; 71(5):807-10. PubMed ID: 23777086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune System Dysregulation in the Progression of Multiple Sclerosis: Molecular Insights and Therapeutic Implications.
    Khan Z; Mehan S; Gupta GD; Narula AS
    Neuroscience; 2024 Jun; 548():9-26. PubMed ID: 38692349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis.
    Link J
    Acta Neurol Scand Suppl; 1994; 158():1-58. PubMed ID: 7732782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine secretion profile of myelin basic protein-specific T cells in multiple sclerosis.
    Rohowsky-Kochan C; Molinaro D; Cook SD
    Mult Scler; 2000 Apr; 6(2):69-77. PubMed ID: 10773850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The pathogenic role of inflammation in multiple sclerosis].
    Martino G; Furlan R; Poliani PL
    Rev Neurol; 2000 Jun 16-30; 30(12):1213-7. PubMed ID: 10935253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of IL-15 in central nervous system disorders.
    Rentzos M; Rombos A
    Acta Neurol Scand; 2012 Feb; 125(2):77-82. PubMed ID: 21615353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.